Brand Description
CARVYKTI® is a genetically modified autologous T cell immunotherapy indicated for treating adult patients with relapsed or refractory multiple myeloma, associated with significant safety warnings and adverse reactions.
Associated Domains
IAB Categories:
Health & Fitness
IAB Ad Products:
Medical and BiotechnologyHealth and Medical Services
| ID | Domain | Seat | Bid | Timestamp | Status | Ad Format | Sub Format | Size | Quality Score | Data Transferred | Computational Cost |
|---|